Oopsie Sting Relief

Manufacturer
4 Visions LLC
Effective date
2026-04-18
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:54:23

Label at a glance#

ProductSting Relief Swab
Active ingredientMENTHOL, UNSPECIFIED FORM, BENZOCAINE
Label structure9 sections

Indications and uses

For temporary relief of pain and itching associated with insect bites and stings.

Dosage and administration

Reverse cardboard sleeve then crush at dot between thumb and forefinger. Once solution has saturated tip, apply topically to the sting or bite. May be used on affected area(s) up to 4 times per day.

Label contents#

Full prescribing information#

Active Ingredients (each swab)

OTC - ACTIVE INGREDIENT SECTION

Benzocaine USP (20%), L-Menthol USP (1%)

Purpose

OTC - PURPOSE SECTION

analgesic

Uses

INDICATIONS & USAGE SECTION

For temporary relief of pain and itching associated with insect bites and stings.

Warnings

WARNINGS SECTION

For external use only

  • do not use in the eyes
  • not for prolonged use
  • do not apply other medications to the same affected areas unless advised by a doctor

Stop use and ask a doctor ifcondition for this preparation is used persists, or if a rash, irritation or allergic reaction develops.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. Not for use with children less than 2 years old without medical advice.If swallowed, get medical help immediately or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Reverse cardboard sleeve then crush at dot between thumb and forefinger. Once solution has saturated tip, apply topically to the sting or bite. May be used on affected area(s) up to 4 times per day.

Other Information

OTHER SAFETY INFORMATION

Store at room temperature away from light.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

D&C Green Dye #5, D&C Yellow Dye #10, FD&C Blue Dye #1, PEG 300 NF, Isopropyl Alcohol USP, Purified Water USP.

Packaging

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PackagePackage

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1037117benzocaine 20 % / menthol 1 % Medicated PadPSN1
1037117benzocaine 200 MG/ML / menthol 10 MG/ML Medicated PadSCD1
1037117benzocaine 20 % / menthol 1 % Topical SwabSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
BENZOCAINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130850042015582GTIN-13: 0850042015582
EAN-13: 0850042015582
GTIN-12: 850042015582
UPC-A: 850042015582
GTIN storage (14 digits): 00850042015582
Dr-Oopsie-Box-v7.jpg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
87251-008-01Sting Relief Swab6 mL in 1 CARTONSWAB61

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
87251-00887251-008-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Sting Relief SwabBENZOCAINE4 Visions LLC4fc7a356-2f1d-85af-e063-6394a90aec6b2026-04-18WarningsExact identifier
ndc (package): 87251-008-01
ndc (product): 87251-008
ndc11 (package): 87251000801
spl id: 4fc7a29a-c176-711a-e063-6294a90a74a7
spl set id: 4fc7a356-2f1d-85af-e063-6394a90aec6b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.